Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGLEC7 | Q9Y286 | 6/20 | 0.44 |
| ▸ | SELL | P14151 | 1/20 | 0.42 |
| ▸ | SELP | P16109 | 1/20 | 0.42 |
| ▸ | MAG | P20916 | 6/20 | 0.41 |
| ▸ | CD22 | P20273 | 6/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19726099 | 0.84 | SIGLEC7 (0.54) | SIGLEC7SELLSELPMAG | |
| SCHEMBL16481536 | 0.84 | SIGLEC7 (0.51) | SIGLEC7SELLSELPMAGCD22 | |
| SCHEMBL15474010 | 0.83 | SIGLEC7 (0.53) | SIGLEC7SELLSELPMAGCD22 | |
| SCHEMBL17988586 | 0.81 | SELL (0.53) | SIGLEC7SELLSELPMAGCD22 | |
| SCHEMBL17199608 | 0.81 | SIGLEC7 (0.50) | SIGLEC7SELLSELPMAGCD22 | |
| SCHEMBL15958878 | 0.81 | SIGLEC7 (0.50) | SIGLEC7SELLSELPMAGCD22 | |
| SCHEMBL15962626 | 0.81 | SIGLEC7 (0.50) | SIGLEC7SELLSELPMAGCD22 | |
| SCHEMBL16348264 | 0.81 | SIGLEC7 (0.50) | SIGLEC7SELLSELPMAGCD22 | |
| SCHEMBL18333621 | 0.81 | SIGLEC7 (0.51) | SIGLEC7SELLSELPMAGCD22 | |
| SCHEMBL15176947 | 0.80 | SIGLEC7 (0.45) | SIGLEC7SELLSELPMAGCD22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170362265-A1 | METHODS FOR MODULAR SYNTHESIS OF N-GLYCANS AND ARRAYS THEREOF | ACADEMIA SINICA (TW) | 2017-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170362265-A1 | METHODS FOR MODULAR SYNTHESIS OF N-GLYCANS AND ARRAYS THEREOF | SIGLEC7, SIGLEC9, CD4 | SIGLEC7 1/4885SELL 223/4885SELP 255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.